Odisha reports four new Covid-19 cases, totaling 49. Dr Nilakantha Mishra urges public to follow health guidelines amid 34 ...

Wall Street gains as S&P 500 surpasses 6,000; key healthcare stock movers revealed. Explore top deals, trends, and regulatory updates in the sector.

Sanofi announced it is punting more than $9 billion to acquire Blueprint Medicines and its Ayvakit, BLU-808 and immunology ...

MOROGORO: TANZANIA has continued to make significant progress in strengthening its health sector, driven by a series of ...

Breakingviews provides financial professionals with unique agenda-setting insight on the major financial news stories as they ...

Late-stage results Otsuka presented in IgA nephropathy triggered a sell-off in Vera shares. Elsewhere, investors scrutinized ...

Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...

Detailed price information for Blueprint Medicines Corp (BPMC-Q) from The Globe and Mail including charting and trades.

President Yoweri Museveni has assured Ugandans that the country is now unstoppable in terms of economic growth and ...

Sanofi picked up Blueprint Medicines in a deal worth up to $9.5 billion. Bristol Myers Squibb will pay $1.5 billion upfront ...

The acquisition includes a rare immunology disease medicine and an advanced and early-stage immunology pipeline.